Healthcare Triangle Inc. has announced a regulatory issue concerning its continued listing on the Nasdaq Stock Market. The company received notices from Nasdaq indicating non-compliance with several listing rules. Initially, the company failed to meet the Minimum Bid Price Requirement, with its securities trading below $1 for 30 consecutive days. Further, Nasdaq raised public interest concerns due to substantial shareholder dilution from a private placement. Additionally, the company's securities recorded a closing bid price of $0.10 or less for ten consecutive trading days, triggering the Low Priced Stocks Rule. Healthcare Triangle Inc. has responded to the Nasdaq Hearings Panel and is exploring alternative actions to regain compliance. However, there is no assurance of meeting the necessary listing requirements.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。